title: Quantitative histopathological assessment of retardation of islets of langerhans degeneration in rosiglitazone-dosed obese ZDF rats using combined insulin and collagens (I and III) immunohistochemistry with automated image analysis and statistical modeling.
abstract: Islets of Langerhans represent a heterogeneous population in insulin resistant and diabetic animals and humans as histological appearances and function vary substantially. Mathematical representation that reflects this morphological diversity will assist in assessment of degeneration and regeneration, enabling comparisons between species, strains, and experimental investigations. Our investigative approach used a model of islet degeneration in diabetic male obese Zucker Diabetic Fatty (ZDF) rats and evaluated its prevention using rosiglitazone treatment. Immunohistochemical staining (insulin and collagens I/III) with automated image analysis reliably measured numbers, area, clustering, and staining intensity of β-cells and degree of islet fibrosis. Finite mixture mathematical modeling for the joint probability distribution of seven islet parameters to represent islet numerical data variation provided an automatic procedure for islet category allocations as normal or abnormal. Allocations for obese ZDF controls and rosiglitazone-treated animals were significantly different, with no significant difference between the latter and lean ZDF controls, indicative of differences within islet populations of individual animals, between lean and obese rat strains and following drug treatment. Islet morphology showed clear association with mathematical characterization. Information on islet morphology obtained by histopathological assessment of single pancreatic tissue sections was confirmed by this method showing drug-induced retardation of islet of Langerhans degeneration.
authors.affiliation: Pathology Group, Global Safety Assessment, Alderley Park, Macclesfield, Cheshire, United Kingdom. huw.jones@astrazeneca.com
authors.forename: Huw B
authors.initials: HB
authors.lastname: Jones
authors.forename: Alison L
authors.initials: AL
authors.lastname: Bigley
authors.forename: John
authors.initials: J
authors.lastname: Pemberton
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Randall
mesh_terms: D000465:Algorithms; D000818:Animals; D024042:Collagen Type I / Q000032:analysis / Q000737:chemistry; D024061:Collagen Type III / Q000032:analysis / Q000737:chemistry; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy* / Q000473:pathology*; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007091:Image Processing, Computer-Assisted / Q000379:methods*; D007150:Immunohistochemistry / Q000379:methods*; D007328:Insulin / Q000032:analysis / Q000737:chemistry; D007515:Islets of Langerhans / Q000187:drug effects / Q000473:pathology*; D008297:Male; D015233:Models, Statistical; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D051381:Rats; D011924:Rats, Zucker; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology*
chemical_list: D024042:Collagen Type I; D024061:Collagen Type III; D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D000077154:Rosiglitazone